Global Rifaximin Market Growth 2025-2031

December 2025 | 85 pages | ID: G0043601F8F9EN
LP Information

Abstracts

The global Rifaximin market size is predicted to grow from US$ 76.4 million in 2025 to US$ 101 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.

Rifaximin is an antibiotic used for the treatment of various conditions such as traveler's diarrhea and hepatic encephalopathy. The global market for rifaximin is being driven by several factors. Here are some key drivers of the rifaximin market?Increased prevalence of infectious diseases: The global prevalence of infectious diseases is on the rise, due to factors such as globalization, increased travel, and climate change. This has led to a higher demand for effective antibiotics like rifaximin. Growing awareness of antibiotic resistance: Antibiotic resistance is a growing concern worldwide, leading to an increased focus on developing and using antibiotics judiciously. Rifaximin is a non-systemic antibiotic, which means it has a lower risk of contributing to antibiotic resistance. This makes it a preferred choice for some indications. Expanding indications: Rifaximin has received regulatory approvals for the treatment of various conditions, including traveler's diarrhea, hepatic encephalopathy, and irritable bowel syndrome. The expanding list of approved indications is contributing to the market growth. Advances in healthcare infrastructure: Improvements in healthcare infrastructure, particularly in emerging markets, have increased access to advanced antibiotics like rifaximin. This has led to a wider patient pool and increased market demand. Rising healthcare expenditure: Governments and private entities are investing heavily in healthcare, including the development and distribution of antibiotics. This increased healthcare spending is supporting the availability and affordability of rifaximin, driving market growth.

LP Information, Inc. (LPI) ' newest research report, the “Rifaximin Industry Forecast” looks at past sales and reviews total world Rifaximin sales in 2024, providing a comprehensive analysis by region and market sector of projected Rifaximin sales for 2025 through 2031. With Rifaximin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rifaximin industry.

This Insight Report provides a comprehensive analysis of the global Rifaximin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rifaximin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rifaximin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rifaximin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rifaximin.

This report presents a comprehensive overview, market shares, and growth opportunities of Rifaximin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 200 mg Tablets
• 550 mg Tablets

Segmentation by Application:

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Salix Pharmaceuticals
• Soigner Pharma
• STERIS PHARMA
• Texas Pharmaceuticals
• Cassopeia Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rifaximin market?

What factors are driving Rifaximin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rifaximin market opportunities vary by end market size?

How does Rifaximin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rifaximin Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Rifaximin by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Rifaximin by Country/Region, 2020, 2024 & 2031
2.2 Rifaximin Segment by Type
  2.2.1 200 mg Tablets
  2.2.2 550 mg Tablets
2.3 Rifaximin Sales by Type
  2.3.1 Global Rifaximin Sales Market Share by Type (2020-2025)
  2.3.2 Global Rifaximin Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Rifaximin Sale Price by Type (2020-2025)
2.4 Rifaximin Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Rifaximin Sales by Application
  2.5.1 Global Rifaximin Sale Market Share by Application (2020-2025)
  2.5.2 Global Rifaximin Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Rifaximin Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Rifaximin Breakdown Data by Company
  3.1.1 Global Rifaximin Annual Sales by Company (2020-2025)
  3.1.2 Global Rifaximin Sales Market Share by Company (2020-2025)
3.2 Global Rifaximin Annual Revenue by Company (2020-2025)
  3.2.1 Global Rifaximin Revenue by Company (2020-2025)
  3.2.2 Global Rifaximin Revenue Market Share by Company (2020-2025)
3.3 Global Rifaximin Sale Price by Company
3.4 Key Manufacturers Rifaximin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Rifaximin Product Location Distribution
  3.4.2 Players Rifaximin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION

4.1 World Historic Rifaximin Market Size by Geographic Region (2020-2025)
  4.1.1 Global Rifaximin Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Rifaximin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rifaximin Market Size by Country/Region (2020-2025)
  4.2.1 Global Rifaximin Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Rifaximin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rifaximin Sales Growth
4.4 APAC Rifaximin Sales Growth
4.5 Europe Rifaximin Sales Growth
4.6 Middle East & Africa Rifaximin Sales Growth

5 AMERICAS

5.1 Americas Rifaximin Sales by Country
  5.1.1 Americas Rifaximin Sales by Country (2020-2025)
  5.1.2 Americas Rifaximin Revenue by Country (2020-2025)
5.2 Americas Rifaximin Sales by Type (2020-2025)
5.3 Americas Rifaximin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rifaximin Sales by Region
  6.1.1 APAC Rifaximin Sales by Region (2020-2025)
  6.1.2 APAC Rifaximin Revenue by Region (2020-2025)
6.2 APAC Rifaximin Sales by Type (2020-2025)
6.3 APAC Rifaximin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Rifaximin by Country
  7.1.1 Europe Rifaximin Sales by Country (2020-2025)
  7.1.2 Europe Rifaximin Revenue by Country (2020-2025)
7.2 Europe Rifaximin Sales by Type (2020-2025)
7.3 Europe Rifaximin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rifaximin by Country
  8.1.1 Middle East & Africa Rifaximin Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Rifaximin Revenue by Country (2020-2025)
8.2 Middle East & Africa Rifaximin Sales by Type (2020-2025)
8.3 Middle East & Africa Rifaximin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rifaximin
10.3 Manufacturing Process Analysis of Rifaximin
10.4 Industry Chain Structure of Rifaximin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Rifaximin Distributors
11.3 Rifaximin Customer

12 WORLD FORECAST REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION

12.1 Global Rifaximin Market Size Forecast by Region
  12.1.1 Global Rifaximin Forecast by Region (2026-2031)
  12.1.2 Global Rifaximin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rifaximin Forecast by Type (2026-2031)
12.7 Global Rifaximin Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Salix Pharmaceuticals
  13.1.1 Salix Pharmaceuticals Company Information
  13.1.2 Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
  13.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Salix Pharmaceuticals Main Business Overview
  13.1.5 Salix Pharmaceuticals Latest Developments
13.2 Soigner Pharma
  13.2.1 Soigner Pharma Company Information
  13.2.2 Soigner Pharma Rifaximin Product Portfolios and Specifications
  13.2.3 Soigner Pharma Rifaximin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Soigner Pharma Main Business Overview
  13.2.5 Soigner Pharma Latest Developments
13.3 STERIS PHARMA
  13.3.1 STERIS PHARMA Company Information
  13.3.2 STERIS PHARMA Rifaximin Product Portfolios and Specifications
  13.3.3 STERIS PHARMA Rifaximin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 STERIS PHARMA Main Business Overview
  13.3.5 STERIS PHARMA Latest Developments
13.4 Texas Pharmaceuticals
  13.4.1 Texas Pharmaceuticals Company Information
  13.4.2 Texas Pharmaceuticals Rifaximin Product Portfolios and Specifications
  13.4.3 Texas Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Texas Pharmaceuticals Main Business Overview
  13.4.5 Texas Pharmaceuticals Latest Developments
13.5 Cassopeia Pharmaceuticals
  13.5.1 Cassopeia Pharmaceuticals Company Information
  13.5.2 Cassopeia Pharmaceuticals Rifaximin Product Portfolios and Specifications
  13.5.3 Cassopeia Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Cassopeia Pharmaceuticals Main Business Overview
  13.5.5 Cassopeia Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rifaximin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rifaximin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 200 mgTablets
Table 4. Major Players of 550 mgTablets
Table 5. Global Rifaximin Sales by Type (2020-2025) & (K Units)
Table 6. Global Rifaximin Sales Market Share by Type (2020-2025)
Table 7. Global Rifaximin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Rifaximin Revenue Market Share by Type (2020-2025)
Table 9. Global Rifaximin Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Rifaximin Sale by Application (2020-2025) & (K Units)
Table 11. Global Rifaximin Sale Market Share by Application (2020-2025)
Table 12. Global Rifaximin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Rifaximin Revenue Market Share by Application (2020-2025)
Table 14. Global Rifaximin Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Rifaximin Sales by Company (2020-2025) & (K Units)
Table 16. Global Rifaximin Sales Market Share by Company (2020-2025)
Table 17. Global Rifaximin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Rifaximin Revenue Market Share by Company (2020-2025)
Table 19. Global Rifaximin Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Rifaximin Producing Area Distribution and Sales Area
Table 21. Players Rifaximin Products Offered
Table 22. Rifaximin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Rifaximin Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Rifaximin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Rifaximin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Rifaximin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Rifaximin Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Rifaximin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Rifaximin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Rifaximin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Rifaximin Sales by Country (2020-2025) & (K Units)
Table 34. Americas Rifaximin Sales Market Share by Country (2020-2025)
Table 35. Americas Rifaximin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Rifaximin Sales by Type (2020-2025) & (K Units)
Table 37. Americas Rifaximin Sales by Application (2020-2025) & (K Units)
Table 38. APAC Rifaximin Sales by Region (2020-2025) & (K Units)
Table 39. APAC Rifaximin Sales Market Share by Region (2020-2025)
Table 40. APAC Rifaximin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Rifaximin Sales by Type (2020-2025) & (K Units)
Table 42. APAC Rifaximin Sales by Application (2020-2025) & (K Units)
Table 43. Europe Rifaximin Sales by Country (2020-2025) & (K Units)
Table 44. Europe Rifaximin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Rifaximin Sales by Type (2020-2025) & (K Units)
Table 46. Europe Rifaximin Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Rifaximin Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Rifaximin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Rifaximin Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Rifaximin Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Rifaximin
Table 52. Key Market Challenges & Risks of Rifaximin
Table 53. Key Industry Trends of Rifaximin
Table 54. Rifaximin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Rifaximin Distributors List
Table 57. Rifaximin Customer List
Table 58. Global Rifaximin Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Rifaximin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Rifaximin Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Rifaximin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Rifaximin Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Rifaximin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Rifaximin Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Rifaximin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Rifaximin Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Rifaximin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Rifaximin Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Rifaximin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Rifaximin Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Rifaximin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Salix Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 73. Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
Table 74. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Salix Pharmaceuticals Main Business
Table 76. Salix Pharmaceuticals Latest Developments
Table 77. Soigner Pharma Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 78. Soigner Pharma Rifaximin Product Portfolios and Specifications
Table 79. Soigner Pharma Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Soigner Pharma Main Business
Table 81. Soigner Pharma Latest Developments
Table 82. STERIS PHARMA Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 83. STERIS PHARMA Rifaximin Product Portfolios and Specifications
Table 84. STERIS PHARMA Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. STERIS PHARMA Main Business
Table 86. STERIS PHARMA Latest Developments
Table 87. Texas Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 88. Texas Pharmaceuticals Rifaximin Product Portfolios and Specifications
Table 89. Texas Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Texas Pharmaceuticals Main Business
Table 91. Texas Pharmaceuticals Latest Developments
Table 92. Cassopeia Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 93. Cassopeia Pharmaceuticals Rifaximin Product Portfolios and Specifications
Table 94. Cassopeia Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Cassopeia Pharmaceuticals Main Business
Table 96. Cassopeia Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Rifaximin
Figure 2. Rifaximin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rifaximin Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rifaximin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rifaximin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rifaximin Sales Market Share by Country/Region (2024)
Figure 10. Rifaximin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 200 mgTablets
Figure 12. Product Picture of 550 mgTablets
Figure 13. Global Rifaximin Sales Market Share by Type in 2025
Figure 14. Global Rifaximin Revenue Market Share by Type (2020-2025)
Figure 15. Rifaximin Consumed in Hospital
Figure 16. Global Rifaximin Market: Hospital (2020-2025) & (K Units)
Figure 17. Rifaximin Consumed in Drug store
Figure 18. Global Rifaximin Market: Drug store (2020-2025) & (K Units)
Figure 19. Global Rifaximin Sale Market Share by Application (2024)
Figure 20. Global Rifaximin Revenue Market Share by Application in 2025
Figure 21. Rifaximin Sales by Company in 2025 (K Units)
Figure 22. Global Rifaximin Sales Market Share by Company in 2025
Figure 23. Rifaximin Revenue by Company in 2025 ($ millions)
Figure 24. Global Rifaximin Revenue Market Share by Company in 2025
Figure 25. Global Rifaximin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Rifaximin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Rifaximin Sales 2020-2025 (K Units)
Figure 28. Americas Rifaximin Revenue 2020-2025 ($ millions)
Figure 29. APAC Rifaximin Sales 2020-2025 (K Units)
Figure 30. APAC Rifaximin Revenue 2020-2025 ($ millions)
Figure 31. Europe Rifaximin Sales 2020-2025 (K Units)
Figure 32. Europe Rifaximin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Rifaximin Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Rifaximin Revenue 2020-2025 ($ millions)
Figure 35. Americas Rifaximin Sales Market Share by Country in 2025
Figure 36. Americas Rifaximin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Rifaximin Sales Market Share by Type (2020-2025)
Figure 38. Americas Rifaximin Sales Market Share by Application (2020-2025)
Figure 39. United States Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Rifaximin Sales Market Share by Region in 2025
Figure 44. APAC Rifaximin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Rifaximin Sales Market Share by Type (2020-2025)
Figure 46. APAC Rifaximin Sales Market Share by Application (2020-2025)
Figure 47. China Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Rifaximin Sales Market Share by Country in 2025
Figure 55. Europe Rifaximin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Rifaximin Sales Market Share by Type (2020-2025)
Figure 57. Europe Rifaximin Sales Market Share by Application (2020-2025)
Figure 58. Germany Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 59. France Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Rifaximin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Rifaximin Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Rifaximin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Rifaximin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Rifaximin in 2025
Figure 72. Manufacturing Process Analysis of Rifaximin
Figure 73. Industry Chain Structure of Rifaximin
Figure 74. Channels of Distribution
Figure 75. Global Rifaximin Sales Market Forecast by Region (2026-2031)
Figure 76. Global Rifaximin Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Rifaximin Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Rifaximin Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Rifaximin Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Rifaximin Revenue Market Share Forecast by Application (2026-2031)